Cancer vaccines: platforms and current progress
Abstract Cancer vaccines, crucial in the immunotherapeutic landscape, are bifurcated into preventive and therapeutic types, both integral to combating oncogenesis. Preventive cancer vaccines, like those against HPV and HBV, reduce the incidence of virus-associated cancers, while therapeutic cancer v...
Saved in:
Main Authors: | Wanting Lei, Kexun Zhou, Ye Lei, Qiu Li, Hong Zhu |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer
2025-01-01
|
Series: | Molecular Biomedicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s43556-024-00241-8 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
mRNA vaccines in the context of cancer treatment: from concept to application
by: Qiang Fu, et al.
Published: (2025-01-01) -
Advances in nucleic acid-based cancer vaccines
by: Hung-Chun Liao, et al.
Published: (2025-01-01) -
Neoantigen mRNA vaccines and A2A receptor antagonism: A strategy to enhance T cell immunity
by: Saber Imani, et al.
Published: (2025-12-01) -
Editorial: Antigen presentation in cancer immune responses
by: Marie-Liesse Asselin-Labat, et al.
Published: (2025-01-01) -
Virus-like particle: a nano-platform that delivers cancer antigens to elicit an anti-tumor immune response
by: Weisen Ning, et al.
Published: (2025-01-01)